These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 28190105)

  • 1. EMT promoting transcription factors as prognostic markers in human breast cancer.
    Matysiak M; Kapka-Skrzypczak L; Jodłowska-Jędrych B; Kruszewski M
    Arch Gynecol Obstet; 2017 Apr; 295(4):817-825. PubMed ID: 28190105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In situ localization of tumor cells associated with the epithelial-mesenchymal transition marker Snail and the prognostic impact of lymphocytes in the tumor microenvironment in invasive ductal breast cancer.
    Alkatout I; Hübner F; Wenners A; Hedderich J; Wiedermann M; Sánchez C; Röcken C; Mathiak M; Maass N; Klapper W
    Exp Mol Pathol; 2017 Apr; 102(2):268-275. PubMed ID: 28232080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCL6 induces EMT by promoting the ZEB1-mediated transcription repression of E-cadherin in breast cancer cells.
    Yu JM; Sun W; Hua F; Xie J; Lin H; Zhou DD; Hu ZW
    Cancer Lett; 2015 Sep; 365(2):190-200. PubMed ID: 26049022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial mesenchymal transition Transcription Factor (TF): The structure, function and microRNA feedback loop.
    Alidadiani N; Ghaderi S; Dilaver N; Bakhshamin S; Bayat M
    Gene; 2018 Oct; 674():115-120. PubMed ID: 29936265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1.
    Ocaña OH; Córcoles R; Fabra A; Moreno-Bueno G; Acloque H; Vega S; Barrallo-Gimeno A; Cano A; Nieto MA
    Cancer Cell; 2012 Dec; 22(6):709-24. PubMed ID: 23201163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion.
    Imani S; Wei C; Cheng J; Khan MA; Fu S; Yang L; Tania M; Zhang X; Xiao X; Zhang X; Fu J
    Oncotarget; 2017 Mar; 8(13):21362-21379. PubMed ID: 28423483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyomavirus enhancer activator 3 protein promotes breast cancer metastatic progression through Snail-induced epithelial-mesenchymal transition.
    Yuen HF; Chan YK; Grills C; McCrudden CM; Gunasekharan V; Shi Z; Wong AS; Lappin TR; Chan KW; Fennell DA; Khoo US; Johnston PG; El-Tanani M
    J Pathol; 2011 May; 224(1):78-89. PubMed ID: 21404275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of epithelial-mesenchymal transition-related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome.
    Jang MH; Kim HJ; Kim EJ; Chung YR; Park SY
    Hum Pathol; 2015 Sep; 46(9):1267-74. PubMed ID: 26170011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vimentin, zeb1 and Sip1 are up-regulated in triple-negative and basal-like breast cancers: association with an aggressive tumour phenotype.
    Karihtala P; Auvinen P; Kauppila S; Haapasaari KM; Jukkola-Vuorinen A; Soini Y
    Breast Cancer Res Treat; 2013 Feb; 138(1):81-90. PubMed ID: 23412770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ubiquitin ligase Siah is a novel regulator of Zeb1 in breast cancer.
    Chen A; Wong CS; Liu MC; House CM; Sceneay J; Bowtell DD; Thompson EW; Möller A
    Oncotarget; 2015 Jan; 6(2):862-73. PubMed ID: 25528765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between circulating tumor cells and epithelial to mesenchymal transition in early breast cancer.
    Mego M; Cierna Z; Janega P; Karaba M; Minarik G; Benca J; Sedlácková T; Sieberova G; Gronesova P; Manasova D; Pindak D; Sufliarsky J; Danihel L; Reuben JM; Mardiak J
    BMC Cancer; 2015 Jul; 15():533. PubMed ID: 26194471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. XBP1 induces snail expression to promote epithelial- to-mesenchymal transition and invasion of breast cancer cells.
    Li H; Chen X; Gao Y; Wu J; Zeng F; Song F
    Cell Signal; 2015 Jan; 27(1):82-9. PubMed ID: 25280941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer.
    Wang QS; Kong PZ; Li XQ; Yang F; Feng YM
    Breast Cancer Res; 2015 Feb; 17(1):30. PubMed ID: 25848863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cells play a potential role in regulating the establishment and maintenance of epithelial-mesenchymal transition in MCF7 human breast cancer cells by paracrine and induced autocrine TGF-β.
    Xu Q; Wang L; Li H; Han Q; Li J; Qu X; Huang S; Zhao RC
    Int J Oncol; 2012 Sep; 41(3):959-68. PubMed ID: 22766682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of aldehyde dehydrogenase 1 and transcription factors in both primary breast cancer and axillary lymph node metastases as a prognostic factor.
    Ito M; Shien T; Omori M; Mizoo T; Iwamoto T; Nogami T; Motoki T; Taira N; Doihara H; Miyoshi S
    Breast Cancer; 2016 May; 23(3):437-44. PubMed ID: 25599843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The EMT-activator ZEB1 induces bone metastasis associated genes including BMP-inhibitors.
    Mock K; Preca BT; Brummer T; Brabletz S; Stemmler MP; Brabletz T
    Oncotarget; 2015 Jun; 6(16):14399-412. PubMed ID: 25973542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanism of epithelial-to-mesenchymal transition and the relationship with tumor metastasis].
    Ma YH; Lu ZH; Chen J
    Zhonghua Bing Li Xue Za Zhi; 2009 Oct; 38(10):715-7. PubMed ID: 20078984
    [No Abstract]   [Full Text] [Related]  

  • 18. Twist2 contributes to breast cancer progression by promoting an epithelial-mesenchymal transition and cancer stem-like cell self-renewal.
    Fang X; Cai Y; Liu J; Wang Z; Wu Q; Zhang Z; Yang CJ; Yuan L; Ouyang G
    Oncogene; 2011 Nov; 30(47):4707-20. PubMed ID: 21602879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 53BP1 suppresses epithelial-mesenchymal transition by downregulating ZEB1 through microRNA-200b/429 in breast cancer.
    Kong X; Ding X; Li X; Gao S; Yang Q
    Cancer Sci; 2015 Aug; 106(8):982-9. PubMed ID: 26011542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PRRX2 as a novel TGF-β-induced factor enhances invasion and migration in mammary epithelial cell and correlates with poor prognosis in breast cancer.
    Juang YL; Jeng YM; Chen CL; Lien HC
    Mol Carcinog; 2016 Dec; 55(12):2247-2259. PubMed ID: 26824226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.